Cutting edge: The Idd3 genetic interval determines regulatory T cell function through CD11b+CD11c- APC

Journal of Immunology

Volumn 181, Issue 11, 2009, Pages 7449-7452

  Anderson, Ana C ^a   Chandwaskar, Rucha ^a   Lee, David H ^a   Kuchroo, Vijay K ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b HARVARD INSTITUTES OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; GLYCOPROTEIN P 15095; INTERLEUKIN 2;

ANIMAL CELL; ANTIGEN PRESENTING CELL; ARTICLE; CELL ACTIVITY; CELL COMPARTMENTALIZATION; CYTOKINE PRODUCTION; FEMALE; GENE LOCUS; LYMPHOCYTE FUNCTION; MOLECULAR MECHANICS; MOUSE; NONHUMAN; NONOBESE DIABETIC MOUSE; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SIGNAL TRANSDUCTION;

EID: 71849090039     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.181.11.7449     Document Type: Article

References (21)

1. Encinas, J. A., L. S. Wicker, L. B. Peterson, A. Mukasa, C. Teuscher, R. Sobel, H. L. Weiner, C. E. Seidman, J. G. Seidman, and V. K. Kuchroo. 1999. QTL influencing autoimmune diabetes and encephalomyelitis map to a 0.15-cM region containing IL2. Nat. Genet. 21: 158-160.
2. Teuscher, C., B. B. Wardell, J. K. Luncerford, S. D. Michael, and K. S. K. Tung. 1996. Aod2, the locus controlling development of atrophy in neonatal thymectomy-induced autoimmune ovarian dysgenesis, co-localizes with Il2, Fgfb, and Idd3. J. Exp. Med. 183: 631-637. (Pubitemid 26059522)
3. Vyse, T. J., and J. A. Todd. 1996. Genetic analysis of autoimmune disease. Cell 85:311-318.
4. Becker, K. G., R. M. Simon, J. E. Bailey-Wilson, B. Freidlin, W. E. Biddison, H. F. McFarland, and J. M. Trent. 1998. Clustering of non-major histocompatibility complex susceptibility candidate loci in human autoimmune diseases. Proc. Natl. Acad. Sci. USA 95: 9979-9984.
5. Lyons, P. A., N. Armitage, F. Argentina, P. Denny, N. J. Hill, C. J. Lord, M. B. Wilusz, L. B. Peterson, L. S. Wicker, and J. A. Todd. 2000. Congenic mapping of the type 1 diabetes locus. Idd3, to a 780-kb region of mouse chromosome 3: identification of a candidate segment of ancestral DNA by haplotype mapping. Genome Res. 10: 446-453.
6. Smith, K. A. 1980. T-cell growth factor. Immunol. Rev. 51: 337-357.
7. Lenardo, M. J. 1991. Interleukin-2 programs mouse αβ T lymphocytes for apoptosis. Nature 353: 858-861.
8. Refaeli, Y., and A. K. Abbas. 1998. Role of cytokines in autoimmunity. Eur. Cytokine. Netw. 9: 81-82.
9. Malek, T. R., and A. L. Bayer. 2004. Tolerance, not immunity crucially depends on IL-2. Nat. Rev. Immunol. 4: 665-674.
10. Encinas, J. A., and V. K. Kuchroo. 1999. Genetics of experimental autoimmune encephalomyelitis. In Genes and Genetics of Autoimmunity, Vol.1. A. N. Theofilopoulos, ed. Karger, Basel, p. 247-272.
11. Vella, A., J. D. Cooper, C. E. Lowe, N. Walker, S. Nutland, B. Widmer, R. Jones, S. M. Ring, W. McArdle, M. E. Pembrey, et al. 2007.Localization of a type 1 diabetes locus in the IL2RA/CD25 region by use of tag single-nucleotide polymorphisms. Am. J. Hum. Genet. 76: 773-779. (Pubitemid 40563099)
12. International Multiple Sclerosis Genetics Consortium, D. A. Hafler, A. Compston, S. Sawcer, E. S. Lander, M. J. Daly, P. L. De Jager, P. I. de Bakker, S. B. Gabriel, D. B. Mirel, et al. 2007. Risk alleles for multiple sclerosis identified by a genomewide study. N. Engl. J. Med. 357: 851-862. (Pubitemid 47347319)
13. Brand, O. J., C. E. Lowe, J. M. Heward, J. A. Franklyn, J. D. Cooper, J. A. Todd, and S. C. Gough. 2007. Association of the interleukin-2 receptor α(IL-2Rα)/CD25 gene region with Grave's disease using a multilocus test and tag SNPs. Clin. Endocrinol. 66:508-512.
14. Podolin, P. L., M. B. Wilusz, R. M. Cubbon, U. Pajvani, C. J. Lord, J. A. Todd, L. B. Peterson, L. S. Wicker, and P. A. Lyons. 2000. Differential glycosylation of interleukin 2, the molecular basis for the NOD Idd3 type I diabetes? Cytokine 12: 477-482.
15. Yamanouchi, J., D. Rainbow, P. Serra, S. Howlett, K. Hunter, V. E. S. Garner, A. Gonzalez-Munoz, J. Clark, R. Veijola, R. Cubbon, et al. 2007. Interleukin-2 gene variation impairs regulatory T cell function and causes autoimmunity. Nat. Genet. 39:329-337. (Pubitemid 46328484)
16. + regulatory T cells in the NOD mouse model of autoimmune diabetes. Proc. Natl. Acad. Sci. USA 104:18181-18186.
17. Tang, Q., J. Y. Adams, A. J. Tooley, M. Bi, B. T. Fife, P. Serra, P. Santamaria, R. M. Locksley, M. F. Krummel, and J. A. Bluestone. 2006. Visualizing regulatory T cell control of autoimmune responses in nonobese diabetic mice. Nat. Immunol. 7:83-92. (Pubitemid 41823872)
18. Granucci, F., S. Feau, V. Angeli, F. Trottein, and P. Ricciardi-Castagnoli. 2003. Early IL-2 production by mouse dendritic cells is the result of microbial-induced priming. J. Immunol. 170: 5075-5081. (Pubitemid 36554737)
19. Belosevic, M., D. S. Finbloom, M. S. Meltzer, and C. A. Nacy. 1990. IL-2. A cofactor for induction of activated macrophage resistance to infection. J. Immunol. 145:831-839. (Pubitemid 20231271)
20. Fukao, T., and S. Koyasu. 2000. Expression of functional IL-2 receptors on mature splenic dendritic cells. Eur. J. Immunol. 30: 1453-1457. (Pubitemid 30311976)
21. + T-cell-mediated regulation and Type1 diabetes development in NOD mice. Diabetes 55: 2098-2105.